FutureChem

At a glance

FutureChem filed 73 disclosures in the last 12 months, including 15 insider, 4 5% holder and 1 issuance. The most recent key filing was on Sep 21: A major holder's stake fell from 12.33% to 12.31% (bonus issue).

Revenue for 2025 was ₩18.7B, up 8% on 2024. It made an operating loss of ₩7.8B. Debt was 36% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩10.6B and operating loss of ₩5.4B.

The 2025 annual report lists 94 employees with an average tenure of 5.3 years and average pay of ₩53.3M, #1543 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩112.1M each on average. It paid no cash dividend for 2025. 지대윤 and related parties held 13.30% at year end.

Of 4 recent 5%+ holder reports, 1 raised and 3 cut a stake; the largest stake reported was 14.33% on Aug 14.

From the 2025 annual report

Staff: 94 (62 men, 32 women), of whom 22 on fixed-term contracts. Total pay for the year: ₩5B. Directors and auditors: 5, paid ₩560.7M in total.

No cash dividend was paid for 2025.

Largest shareholder

지대윤 holds 5.99%; with 5 related parties the group holds 13.30% of common shares at year end.

Auditor: 신한회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports